Analysis of CD10+ hairy cell leukemia

Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expres...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of clinical pathology 2003-08, Vol.120 (2), p.228-235
Hauptverfasser: JASIONOWSKI, Tammy M, HARTUNG, Leah, GREENWOOD, Jay H, PERKINS, Sherrie L, BAHLER, David W
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 235
container_issue 2
container_start_page 228
container_title American journal of clinical pathology
container_volume 120
creator JASIONOWSKI, Tammy M
HARTUNG, Leah
GREENWOOD, Jay H
PERKINS, Sherrie L
BAHLER, David W
description Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6. Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10-HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.
doi_str_mv 10.1309/QVJD31TEG9UJ18BQ
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73584151</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>19518053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-a6f7b43566d236f83dc73e3978023821a754f981e3e24779cf87ec3f04d5f91e3</originalsourceid><addsrcrecordid>eNqFkMFLwzAUxoMobk7vnqSXeZFqXl7SJMe5zekYyGDzWrI0wWq7zmY97L-3Y4OBF08PPn7fx-NHyC3QR0Cqn-Yf0xHCYjzRyymo5_kZ6YLmGEvJ2DnpUkpZrEFih1yF8EUpMEX5JekA0whCYJf0B2tT7EIeospHwxHQh-jT5PUusq4oosI1367MzTW58KYI7uZ4e2T5Ml4MX-PZ--RtOJjFlidqG5vEyxVHkSQZw8QrzKxEh1oqylAxMFJwrxU4dIxLqa1X0ln0lGfC6zbukfvD7qaufhoXtmmZh_0nZu2qJqQSheIg4F8QtABFBbYgPYC2rkKonU83dV6aepcCTfcO078O28rdcbtZlS47FY7SWqB_BEywpvC1Wds8nDhBOWCS4C-3y3az</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19518053</pqid></control><display><type>article</type><title>Analysis of CD10+ hairy cell leukemia</title><source>MEDLINE</source><source>Oxford University Press</source><source>EZB Electronic Journals Library</source><creator>JASIONOWSKI, Tammy M ; HARTUNG, Leah ; GREENWOOD, Jay H ; PERKINS, Sherrie L ; BAHLER, David W</creator><creatorcontrib>JASIONOWSKI, Tammy M ; HARTUNG, Leah ; GREENWOOD, Jay H ; PERKINS, Sherrie L ; BAHLER, David W</creatorcontrib><description>Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6. Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10-HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.</description><identifier>ISSN: 0002-9173</identifier><identifier>EISSN: 1943-7722</identifier><identifier>DOI: 10.1309/QVJD31TEG9UJ18BQ</identifier><identifier>PMID: 12931553</identifier><identifier>CODEN: AJCPAI</identifier><language>eng</language><publisher>Chicago, IL: American Society of Clinical Pathologists</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Biological and medical sciences ; Biomarkers, Tumor - metabolism ; Female ; Flow Cytometry ; Hematologic and hematopoietic diseases ; Humans ; Immunoenzyme Techniques ; Immunophenotyping ; Leukemia, Hairy Cell - immunology ; Leukemia, Hairy Cell - metabolism ; Leukemia, Hairy Cell - pathology ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; Male ; Medical sciences ; Middle Aged ; Neprilysin - immunology ; Neprilysin - metabolism</subject><ispartof>American journal of clinical pathology, 2003-08, Vol.120 (2), p.228-235</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-a6f7b43566d236f83dc73e3978023821a754f981e3e24779cf87ec3f04d5f91e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15041366$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12931553$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JASIONOWSKI, Tammy M</creatorcontrib><creatorcontrib>HARTUNG, Leah</creatorcontrib><creatorcontrib>GREENWOOD, Jay H</creatorcontrib><creatorcontrib>PERKINS, Sherrie L</creatorcontrib><creatorcontrib>BAHLER, David W</creatorcontrib><title>Analysis of CD10+ hairy cell leukemia</title><title>American journal of clinical pathology</title><addtitle>Am J Clin Pathol</addtitle><description>Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6. Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10-HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Biological and medical sciences</subject><subject>Biomarkers, Tumor - metabolism</subject><subject>Female</subject><subject>Flow Cytometry</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Immunophenotyping</subject><subject>Leukemia, Hairy Cell - immunology</subject><subject>Leukemia, Hairy Cell - metabolism</subject><subject>Leukemia, Hairy Cell - pathology</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neprilysin - immunology</subject><subject>Neprilysin - metabolism</subject><issn>0002-9173</issn><issn>1943-7722</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMFLwzAUxoMobk7vnqSXeZFqXl7SJMe5zekYyGDzWrI0wWq7zmY97L-3Y4OBF08PPn7fx-NHyC3QR0Cqn-Yf0xHCYjzRyymo5_kZ6YLmGEvJ2DnpUkpZrEFih1yF8EUpMEX5JekA0whCYJf0B2tT7EIeospHwxHQh-jT5PUusq4oosI1367MzTW58KYI7uZ4e2T5Ml4MX-PZ--RtOJjFlidqG5vEyxVHkSQZw8QrzKxEh1oqylAxMFJwrxU4dIxLqa1X0ln0lGfC6zbukfvD7qaufhoXtmmZh_0nZu2qJqQSheIg4F8QtABFBbYgPYC2rkKonU83dV6aepcCTfcO078O28rdcbtZlS47FY7SWqB_BEywpvC1Wds8nDhBOWCS4C-3y3az</recordid><startdate>20030801</startdate><enddate>20030801</enddate><creator>JASIONOWSKI, Tammy M</creator><creator>HARTUNG, Leah</creator><creator>GREENWOOD, Jay H</creator><creator>PERKINS, Sherrie L</creator><creator>BAHLER, David W</creator><general>American Society of Clinical Pathologists</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20030801</creationdate><title>Analysis of CD10+ hairy cell leukemia</title><author>JASIONOWSKI, Tammy M ; HARTUNG, Leah ; GREENWOOD, Jay H ; PERKINS, Sherrie L ; BAHLER, David W</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-a6f7b43566d236f83dc73e3978023821a754f981e3e24779cf87ec3f04d5f91e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Biological and medical sciences</topic><topic>Biomarkers, Tumor - metabolism</topic><topic>Female</topic><topic>Flow Cytometry</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Immunophenotyping</topic><topic>Leukemia, Hairy Cell - immunology</topic><topic>Leukemia, Hairy Cell - metabolism</topic><topic>Leukemia, Hairy Cell - pathology</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neprilysin - immunology</topic><topic>Neprilysin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JASIONOWSKI, Tammy M</creatorcontrib><creatorcontrib>HARTUNG, Leah</creatorcontrib><creatorcontrib>GREENWOOD, Jay H</creatorcontrib><creatorcontrib>PERKINS, Sherrie L</creatorcontrib><creatorcontrib>BAHLER, David W</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of clinical pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JASIONOWSKI, Tammy M</au><au>HARTUNG, Leah</au><au>GREENWOOD, Jay H</au><au>PERKINS, Sherrie L</au><au>BAHLER, David W</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of CD10+ hairy cell leukemia</atitle><jtitle>American journal of clinical pathology</jtitle><addtitle>Am J Clin Pathol</addtitle><date>2003-08-01</date><risdate>2003</risdate><volume>120</volume><issue>2</issue><spage>228</spage><epage>235</epage><pages>228-235</pages><issn>0002-9173</issn><eissn>1943-7722</eissn><coden>AJCPAI</coden><abstract>Hairy cell leukemia (HCL) has been reported to sometimes express CD10. However, the reported frequencies have been quite variable and the significance of CD10 expression has not been addressed. Cases of HCL submitted to our flow cytometry service during a 2-year period were evaluated for CD10 expression. Information regarding demographics, clinical manifestations, tissue morphologic features, and response to treatment was reviewed. Of the 97 HCL cases identified, 10 expressed CD10. The level of CD10 staining was typically well above control levels and also could be detected easily by immunohistochemical analysis. All cases analyzed were negative for bcl-6. Our study suggests that approximately 10% of otherwise typical cases of HCL show aberrant CD10 expression. CD10+ HCL cases seem to be morphologically and clinically similar to CD10-HCL cases. Appreciating that HCL can express CD10 may be especially important when evaluating specimens with suboptimal morphologic features and/or limited immunophenotyping panels.</abstract><cop>Chicago, IL</cop><pub>American Society of Clinical Pathologists</pub><pmid>12931553</pmid><doi>10.1309/QVJD31TEG9UJ18BQ</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0002-9173
ispartof American journal of clinical pathology, 2003-08, Vol.120 (2), p.228-235
issn 0002-9173
1943-7722
language eng
recordid cdi_proquest_miscellaneous_73584151
source MEDLINE; Oxford University Press; EZB Electronic Journals Library
subjects Adult
Aged
Aged, 80 and over
Biological and medical sciences
Biomarkers, Tumor - metabolism
Female
Flow Cytometry
Hematologic and hematopoietic diseases
Humans
Immunoenzyme Techniques
Immunophenotyping
Leukemia, Hairy Cell - immunology
Leukemia, Hairy Cell - metabolism
Leukemia, Hairy Cell - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Male
Medical sciences
Middle Aged
Neprilysin - immunology
Neprilysin - metabolism
title Analysis of CD10+ hairy cell leukemia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T20%3A08%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20CD10+%20hairy%20cell%20leukemia&rft.jtitle=American%20journal%20of%20clinical%20pathology&rft.au=JASIONOWSKI,%20Tammy%20M&rft.date=2003-08-01&rft.volume=120&rft.issue=2&rft.spage=228&rft.epage=235&rft.pages=228-235&rft.issn=0002-9173&rft.eissn=1943-7722&rft.coden=AJCPAI&rft_id=info:doi/10.1309/QVJD31TEG9UJ18BQ&rft_dat=%3Cproquest_cross%3E19518053%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19518053&rft_id=info:pmid/12931553&rfr_iscdi=true